Abbott reports few adverse events in drug-coated stent study

05/21/2009 | CNNMoney

Abbott Laboratories said patients who received its Xience drug-eluting stent had few instances of repeat procedures or major cardiac events during a one-year study on more than 2,000 patients outside the U.S. The findings are similar to results from two clinical trials that helped Abbott secure marketing approval for the device in the U.S. and Europe.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN